The J-Curve in Private Equity

The J-curve is the shape that a private equity fund's cumulative net cash flow and reported net returns trace over its life: negative in the early years, then rising as investments mature and are sold.

Reviewed by Peleg Chevion, Managing Partner

Two curves carry the name. The cash-flow curve is the running total of distributions less contributions. The net asset value (NAV) curve compares reported value plus distributions with capital paid in, usually as total value to paid-in capital (TVPI) or net internal rate of return (IRR). Cambridge Associates observes that the reported returns "often resemble the shape of the letter “J” when graphed" (A Framework for Benchmarking Private Investments).

Mechanism

Three forces produce the shape. The first is fees. Cambridge Associates writes that early in a fund's life "the payment of management fees without corresponding increases in portfolio company valuation often results in negative returns for a few years." The ILPA Principles 3.0 (2019) contemplate a commitment-based fee during the investment period and recommend a step-down to a percentage of unrealized cost afterward.

The second is the order of cash: contributions pay for deals and fees at once, while distributions require exits. The third is valuation judgment. Cambridge Associates notes that "managers have some latitude as to how they value investments," and the IPEV valuation FAQ directs valuers to weigh "performance against milestones in the context of the investment thesis."

NAV is the amount by which a fund's assets exceed its debt and liabilities, and TVPI is cumulative distributions plus NAV, divided by cumulative contributions, as the ILPA Principles 3.0 glossary defines them.

The worked example’s hypothetical $100 million fund, $ millions. The solid line is cumulative net cash flow; the dashed line is distributions plus NAV less contributions. Sources: Cambridge Associates, A Framework for Benchmarking Private Investments; ILPA, Principles 3.0 (2019).

Worked Example

Consider a hypothetical $100 million fund, the same fund that the TVPI and DPI entries use. Paid-in capital reaches $95 million, so the fund never calls its full commitment. Contributions include management fees and expenses, and the $5 million contribution in year 8 is a recall of capital distributed earlier.

Hypothetical $100 million fund, millions of dollars
Year	Contributions	Distributions	Net cash flow	Cumulative net cash flow	Year-end NAV	TVPI	Net IRR since inception
1	15	0	−15	−15	12	0.80x	n/a
2	15	0	−15	−30	26	0.87x	−26.7%
3	10	0	−10	−40	36	0.90x	−9.2%
4	15	0	−15	−55	54	0.98x	−1.2%
5	15	5	−10	−65	72	1.10x	4.8%
6	10	15	5	−60	76	1.20x	7.1%
7	10	26	16	−44	84	1.44x	12.1%
8	5	34	29	−15	78	1.66x	14.3%
9	0	50	50	35	50	1.89x	15.7%
10	0	41	41	76	19	2.00x	15.9%
Total	95	171	76

Cumulative net cash flow bottoms at −$65 million in year 5, turns positive during year 9, and ends at +$76 million. The NAV curve turns sooner: TVPI is 0.80x, 0.87x, 0.90x and 0.98x in years 1 to 4, then 1.10x in year 5, because unrealized investments are carried at estimated fair value before cash returns. Distributions to paid-in capital (DPI) reaches 1.0x only in year 9, at 1.37x. Years 3, 6 and 10 match the TVPI entry.

Net IRR since inception treats each year’s net cash flow as occurring at year-end and the year-end NAV as a terminal value, so it is not defined in year 1, when the contribution and the valuation fall on the same date. It is −26.7 percent at year 2, −9.2 percent at year 3 and −1.2 percent at year 4, turns positive at 4.8 percent in year 5 and rises to 15.9 percent at year 10, which is the J that Cambridge Associates describes.

Subscription lines change the reported curve without changing the investments. ILPA's June 2017 guidance states that delaying capital calls "shortens the J-curve, enhancing the fund’s Internal Rate of Return (IRR), particularly early in a fund’s life." Its notional example, with one $100 investment, $2 of annual management fees and a $162 realization in year six, reports an IRR of 6.62 percent and a TVPI of 1.45x without a facility, 7.14 percent and 1.40x with a one-year facility, and 7.98 percent and 1.35x with a two-year facility. The rate rises while the multiple falls, because the fund pays interest and fees.

ILPA's January 2025 Performance Template calls for net IRR and TVPI "both with and without the impact of fund-level subscription facilities" for funds commencing operations on or after January 1, 2026.

What It Means for a Limited Partner

For an allocator, the curve is a reporting pattern and not a forecast. A TVPI below 1.00x in the early years, as in years 1 to 4 of the example, is the expected product of fees and early marks and says little about a manager.

Compare funds of the same vintage and age, and prefer TVPI to IRR early, because the ILPA Principles 3.0 glossary calls TVPI the preferable measure before the end of a fund's life. Ask for net IRR with and without any subscription line, as ILPA’s 2017 and 2020 guidance recommends, and for TVPI on the same basis, as ILPA Principles 3.0 and the January 2025 Performance Template call for. Model cash as well as returns: the $65 million maximum net outflow in the example is the liquidity an allocator must be prepared to fund, and ILPA's 2020 guidance ties line disclosure to an LP's "cash flow modeling and commitment pacing."

In Life Sciences and Healthcare

Clinical development lengthens and roughens the curve. BIO, Informa Pharma Intelligence and QLS Advisors report that, across 2011 through 2020, a drug candidate took an average of 10.5 years to move from Phase I to approval, that 7.9 percent of Phase I candidates were approved, and that 28.9 percent advanced out of Phase II. These are drug-development statistics, not fund statistics, but they explain why value in a clinical-stage portfolio tends to move in steps at trial readouts and financings, so that a failed readout can lower NAV in a year when cash flow is unchanged.

Governing Authority and Sources

Cambridge Associates, A Framework for Benchmarking Private Investments.
ILPA, Principles 3.0 (2019).
ILPA, Subscription Lines of Credit and Alignment of Interests (June 2017).
ILPA, Guidance on Disclosures Related to Subscription Lines of Credit (June 2020).
ILPA, Performance Template Guidance, Granular Methodology (January 2025).
IPEV Board, Valuation Guidelines FAQs.
BIO, Informa Pharma Intelligence and QLS Advisors, Clinical Development Success Rates and Contributing Factors 2011–2020.

Frequently Asked Questions

What is a J-curve in private equity?

It is the pattern in which a private equity fund's cumulative net cash flow and reported net returns are negative in the early years and turn positive as investments mature and are sold. Plotted over time, either series resembles the letter J.

What causes the J-curve effect?

Fees, the order of cash and early valuations cause it. Cambridge Associates attributes the early dip to management fees paid without corresponding increases in portfolio company valuation. Capital is contributed before exits return it, and reported values reflect manager judgment, so net returns often stay negative for a few years.

Can the J-curve be mitigated?

The reported curve can be shortened, but the investments do not change. Subscription lines delay capital calls, which ILPA's 2017 guidance says shortens the J-curve and raises IRR, especially early in a fund's life. ILPA therefore asks managers to report returns both with and without the line.

Read this entry with the pillar on growth equity, and with the related entries Total Value to Paid-In, Distributions to Paid-In Capital and Capital Call.